الرئيسية › دليل الباحثين › Mebarka Ouassaf
Mebarka Ouassaf
الانتماء : University of Biskra
- 52منشورات (انتماء جزائري)
- 60مجموع المنشورات
- 841الاستشهادات
- 15مؤشر h
الملف البحثي
لدى Mebarka Ouassaf 52 منشور(ات) مفهرسة (2018–2026). تُنشر أعماله أساسًا في «Journal of Biomolecular Structure and Dynamics»، «Zenodo (CERN European Organization for Nuclear Research)» و«Molecules». أكثر مقالاته استشهادًا هو «Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular d» (2022)، وقد استُشهد به 86 مرة. 31 من هذه المنشورات تعود إلى آخر ثلاث سنوات من النشاط. شارك في تأليف أعماله 12 باحثًا على الأقل، منهم باحثون من مؤسسات في المغرب.
هل هذا أنت؟ عرّف بأبحاثك
أنشئ ملفك على DzCademia مجانًا وأضف مقالاتك: ستظهر بسهولة أكبر على Google وفي مساعدي الذكاء الاصطناعي مثل ChatGPT، فيقرؤها ويستشهد بها عدد أكبر من الناس.
إنشاء ملفي المجاني إضافة منشوراتيمجالات البحث
- Computational Drug Discovery Methods
- Synthesis and Characterization of Heterocyclic Compounds
- SARS-CoV-2 and COVID-19 Research
- Cholinesterase and Neurodegenerative Diseases
- Machine Learning in Materials Science
المنشورات (52)
- Integrated in silico approach identifies Chrysosplenol D from Artemisia annua as a potent candidate against SARS-CoV-2, MERS-CoV, and HSV-2 proteases
- An Explainable 2D-QSAR Machine Learning Approach for Predicting COX-2 Inhibitory Activity Using Molecular Fingerprints
- MERS-Mpro Predictor: A Machine Learning-Based Tool for Rapid Screening of Potential MERS-CoV Main Protease Inhibitors
- Supplementary Code, Data, and Workflow for the PARP1 Activity Predictor
- DDI-HierPred Dataset: Curated Drug–Drug Interaction Data for Hierarchical PK/PD Classification and Interaction Subtype Prediction
- QSAR Studio: An Integrated Platform for End-to-End Classification-Based QSAR Modeling
- Integrated Protein–Protein Interaction Network Data for SARS-CoV-2, Acinetobacter baumannii, and Human Host Co-infection Analysis
- DDI-HierPred: An Artificial Intelligence-Based Hierarchical PK/PD Platform for Drug–Drug Interaction Prediction
- Identification of natural TLR4 modulators through network pharmacology and molecular modeling in SARS-CoV-2 Acinetobacter baumannii co-infection
- Machine Learning-Guided Screening and Molecular Docking for Proposing Naturally Derived Drug Candidates Against MERS-CoV 3CL Protease
- In Silico Network Pharmacology, Molecular Docking, and Molecular Dynamics Analysis of Rosemary-Derived Compounds as Potential HSP90 Inhibitors for Cancer Therapy
- Discovery of Novel Natural Inhibitors of H5N1 Neuraminidase Using Integrated Molecular Modeling and ADMET Prediction
- Integrated in silico approach for discovering novel HCV NS3/4A protease inhibitors: virtual screening, docking, and dynamic simulation
- Deep learning-guided discovery of selective JAK2-JH2 allosteric inhibitors: integration of MLP predictive modeling, BREED-based library design, and computational validation
- DeepTargetClass: a web-based platform for predicting protein target classes of small molecules
- In silico study of possible Marburg virus VP35 inhibitors using structure based virtual screening, ADMET, stability approach via DFT and molecular dynamics simulations
- An Integrated Computational Approach to Identify Potent HIV-1 Protease Inhibitors from Marine Sources
- Valorization of a Natural Compound Library in Exploring Potential Marburg Virus VP35 Cofactor Inhibitors via an In Silico Drug Discovery Strategy
- Natural‐Product‐Based Discovery of Zika Virus NS5‐RdRp Inhibitors via Structure‐Based Design and Quantum Reactivity Filters
- Molecular docking, ADME-Tox, DFT and molecular dynamics simulation of butyroyl glucopyranoside derivatives against DNA gyrase inhibitors as antimicrobial agents
- Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations
- Clinical informatics and molecular hybridization of established clinical DPP-4 inhibitors to generate next-level diabetes type 2 drugs
- Exploring potential therapeutics: Targeting dengue virus NS5 through molecular docking, ADMET profiling, and DFT analysis
- Computational studies of pyrimidine derivatives as inhibitors of human σ1 receptor using 3D-QSAR analysis, molecular docking, ADMET properties and DFT investigation
- Discovery of N-Aryl-Benzimidazolone Analogs as Novel Potential HSP90 Inhibitors: A Computational Approach
- Identification and Evaluation of Natural Compounds as Potential Inhibitors of NS2B-NS3 Zika Virus Protease: A Computational Approach
- Exploring the Antiviral Potential of Artemisia annua Through JAK-STAT Pathway Targeting: A Network Pharmacology Approach
- Novel therapeutic agents for H5N1 influenza virus through 3D-QSAR, molecular docking, ADMET prediction, and DFT based global reactivity descriptors
- Exploring the efficacy of natural compounds against SARS-CoV-2: A synergistic approach integrating molecular docking and dynamic simulation
- Computational Study of Coumarin Compounds as Potential Inhibitors of Casein Kinase 2: DFT, 2D-QSAR, ADMET and Molecular Docking Investigations
- Potential novel HIV-1 reverse transcriptase inhibitors: a modeling and evaluation approach
- Marine-Derived Compounds as Potential Inhibitors of Hsp90 for Anticancer and Antimicrobial Drug Development: A Comprehensive In Silico Study
- Pharmacoinformatics and Breed-Based De Novo Hybridization Studies to Develop New Neuraminidase Inhibitors as Potential Anti-Influenza Agents
- Pharmacophore-based virtual screening, molecular docking and molecular dynamics studies for the discovery of novel neuraminidase inhibitors
- Discovery of novel potent drugs for influenza by inhibiting the vital function of neuraminidase via fragment-based drug design (FBDD) and molecular dynamics simulation strategies
- Comparative Molecular Field Analysis (CoMFA), Molecular Docking and ADMET Study on Thiazolidine-4-carboxylic acid Derivatives as New Neuraminidase Inhibitors
- Design of novel benzimidazole derivatives as potential α-amylase inhibitors using QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation studies
- Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations
- In silico investigation of phytoconstituents from Cameroonian medicinal plants towards COVID-19 treatment
- Pharmacophore-based virtual screening, molecular docking, and molecular dynamics studies for the discovery of novel FLT3 inhibitors
- Combined Pharmacophore Modeling, 3D-QSAR, Molecular Docking and Molecular Dynamics Study on Indolyl-aryl-sulfone Derivatives as New HIV1 Inhibitors
- TARGETING THE MAIN PROTEASE AND THE SPIKE PROTEIN OF SARS-COV-2 WITH NATURALLY OCCURRING COMPOUNDS FROM SOME CAMEROONIAN MEDICINAL PLANTS: AN IN-SILICO STUDY FOR DRUG DESIGNING
- Quantitative Structure Activity Relationship (QSAR) Investigations and Molecular Docking Analysis of Plasmodium Protein Farnesyltransferase Inhibitors as Potent Antimalarial Agents
- PASS prediction, molecular docking and pharmacokinetic studies of acyl substituted bioactive galactopyranoside esters as antibacterial agents
- Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease
- Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors
- Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2
- Combined 3D-QSAR and Molecular Docking Analysis of Thienopyrimidine Derivatives as Staphylococcus aureus Inhibitors
- Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors
- Molecular docking studies for the identifications of novel antimicrobial compounds targeting of staphylococcus aureus
- Quantitative Structure-Activity Relationships of 1.2.3 Triazole Derivatives as Aromatase Inhibition Activity
- DRUG LIKENESS SCORING AND STRUCTURE ACTIVITY/PROPERTY RELATIONSHIPS OF 1,2,3-TRIAZOLE DERIVATEVES AS AROMATASE INHIBITOR
مجلات النشر
- Journal of Biomolecular Structure and Dynamics × 6
- Zenodo (CERN European Organization for Nuclear Research) × 4
- Molecules × 3
- Acta chimica slovenica × 3
- Pharmaceuticals × 2
- International Journal of Molecular Sciences × 2
المنشورات حسب السنة
- 20269
- 202510
- 202412
- 20235
- 20228
- 20214
- 20203
- 20181
التعاون العلمي
المؤسسات الشريكة : University of Eloued · Université des Sciences et de la Technologie d'Oran Mohamed Boudiaf · University of Hassan II Casablanca · University Frères Mentouri Constantine 1 · Université Larbi Tébessi
بلدان المؤلفين المشاركين : المغرب
المؤلفون المشاركون
- Salah Belaıdı
- Lotfi Bourougaa
- Afaf Zekri
- Radhia Mazri
- Mohamed Mouadh Messaoui
- Nada Anede
- Touhami Lanez
- Houmam Belaıdı
- Aicha Kerassa
- Hind Yassmine Chennai
- Saida Khamoulı
- Noureddine Tchouar
البيانات البيبليوغرافية مصدرها OpenAlex (قاعدة مفتوحة).
لماذا تختارون DzCademia؟
ملفات أكاديمية ومقالات ومداخلات علمية: امنحوا أبحاثكم حضوراً عاماً منظماً. تساعد البيانات الوصفية المدمجة محركات البحث ومساعدات الذكاء الاصطناعي على التعرف على أعمالكم وفهم مراجعها.
علّق عبر Google
سجّل الدخول عبر Google للتعليق مباشرة على هذه الصفحة.